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PreviewsThese apparently discrepant findings
reveal the ambiguous, Janus-headed
nature of infection in CD8+ T cell-medi-
ated brain autoimmunity. On the one
hand, (mild) peripheral infection seems
to be required for maintaining purg-
ing of autoimmune CD8+ T cells from
the immune repertoire, while, on the
other hand, local infection may condition
CNS tissue to be attacked by these
T cells.
Time will tell how far these observations
will apply to the pathogenesis of MS. Do
infectious episodes impinge on T cell-
mediated self-tolerance on the one hand
and trigger disease bouts on the other?
Could the commensal gut flora have10 Immunity 37, July 27, 2012 ª2012 Elseviea role in these discrepant aspects of auto-
immunity? Before reaching conclusive
answers, we will have to learn whether
the CD8+ T cells dominating the active
MS lesions are indeed pathogenic effec-
tors or whether they act as regulators
of another pathogenic mechanism. The
CD8 question will be vexing for some
time to come.REFERENCES
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The mechanisms of how commensal bacteria impact systemic immunity are unclear. In this issue of
Immunity, Abt et al. (2012) and Ganal et al. (2012) demonstrate that microbiota poise macrophages for
induction of the type I interferon pathway after virus infection.Commensal bacteria facilitate multiple
aspects of intestinal homeostasis. In
addition to promoting structural and
metabolic functions, microbiota stimulate
the development of lymphoid follicles, IgA
production, antimicrobial proteins, and
accumulation of intraepithelial lympho-
cytes (Honda and Littman, 2012). Thus,
microbiota help to protect their host
from intestinal pathogens. Two studies in
this issue now demonstrate a crucial role
for commensal bacteria in controlling
systemic antiviral immunity. Both groups
discovered that the ability of phagocytic
cells to rapidly produce type I interferons
(IFNs) after virus infection requires a
conditioning phase of tonic signaling
through the type I IFN receptor (IFN-R),
and intestinal microbes were providing
this signal in the steady state. These
findings reveal a previously unknownpathway in which commensal organisms
augment macrophage responsiveness to
viruses by modulating their threshold of
activation.
Antiviral immune defense is coordi-
nated by dendritic cells (DCs) and natural
killer (NK) cells. In peripheral tissues,
DCs detect viral nucleic acids, resulting
in their migration to lymph nodes and
production of IFNs, which have broad
immunological effects (Gonza´lez-Navajas
et al., 2012). Autocrine signaling of type I
IFNs on DCs increases their expression
of antigen presenting and costimulatory
molecules, leading to CD8+ T cell clonal
expansion and effector differentiation.
Activated DCs also prime NK cell function
by producing cytokines involved in their
survival (IL-15), lytic activity (type I IFN),
and IFN-g production (IL-12). The direct
action of type I IFNs on CD8+ T cellspromotes their cytotoxic function against
infected cells in the periphery, which
present viral antigens on MHC class I. In
contrast, the ability of NK cells to sense
and lyse infected cells is controlled by
a complex set of activating and inhibitory
receptors. The overall effects of type I
IFNs on distinct cell types are mediated
by the binding of IRF family transcription
factors to hundreds of gene promoters
containing IFN-stimulated response
elements (ISREs). Thus, the regulation of
type I IFN activity is central to antiviral
host defense.
To study the role of commensal bac-
teria in systemic antiviral immunity, the
authors analyzed germ-free (GF) mice
(Ganal et al., 2012), or conventional mice
placed on water containing broad-
spectrum antibiotics (ABX; Abt et al.,
2012). In each of these cases, the absence
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Figure 1. Tonic Type I IFN Signaling Poises Innate Immune Defense against Viruses
Newly formed mononuclear phagocytes (APCs) migrate to peripheral tissues and survey the immunolog-
ical environment. Pattern recognition receptors, possibly Toll-like receptor (TLRs), detect microbial
products that translocate from the gut into the circulation, such as cell wall molecules (LPS) and nucleic
acids. This results in the activation of IRF3, which translocates to the nucleus and initiates the expression
of type I IFNs (Ifnb). The autocrine action of IFNs results in STAT1 phosphorylation, translocation, and
binding to promoter regions containing ISREs. This constant, low-level tonic stimulation by microbial
products causes chromatin remodeling of antiviral genes including the genes encoding Mda5 (Ifih1)
and RIG-I (Ddx58), which now contain epigenetic markers of transcriptionally active genes. In poised
APCs, the activation of multiple transcription factors (IRFs, STATs, and NF-kB) combined with open chro-
matin results in robust production of type I IFNs during virus infections. In contrast, in animals with
depleted commensal microbiota, the promoter regions of these genes retain a closed conformation,
dampening a vigorous IFN response. As a result, animals with depleted commensal microbiota cannot
control early virus replication and succumb to infection. Intestinal colonization provides a positive feed-
back loop to initiate a rapid IFN transcriptional program after systemic viral infection.
Immunity
Previewsof commensal microbiota increased
susceptibility to intravenous (i.v.) or intra-
nasal (i.n.) viral infections. This was asso-
ciated with decreased lymphocyte func-
tion. For instance, intestinal colonization
was required for optimal NK cell cytotoxic
activity, CD8+ T cell clonal expansion,
and virus-specific antibody production.
The impact of commensal bacteria on
multiple parameters of anti-viral immunity
suggested they may influence virus
recognition by innate immune cells.
Indeed, depletion of microbiota prior to
infection blunted the type I IFN response.
This was reflected by the downregu-
lation of many type I IFN pathway genes
in macrophages obtained from antibi-
otic-treated mice, including the genes
encoding Mda5 and RIG-I which bothdetect viral RNA. Further, antibiotic treat-
ment decreased STAT1 phosphorylation
after stimulation with IFN-g or IFN-b (Abt
et al., 2012). Splenic DCs from GF mice
were unable to upregulate type I IFNs,
IL-15, or IL-15Ra following treatment
with poly-IC (Ganal et al., 2012). This was
associated with decreased binding of the
transcription factors IRF3, NFkB p65,
and RNA polymerase II to promoter
regions of Ifnb1 and Il6. Interferon-induc-
ible genes in GF DCs were found to
contain lower amounts of trimethylated
histone H3K4, a marker of active gene
transcription. Despite these defects in
signaling and gene expression, antiviral
immunity could be restored by injecting
the commensal-depleted mice with poly-
IC or type I IFNs, suggesting that theImmunmicrobiota set the threshold for TLR3
signaling. Taken together, these studies
demonstrate that tonic signaling by type I
IFNs on antigen-presenting cells (APCs)
is required for efficient viral recognition
and generation of adaptive immunity and
that this signal is provided by commensal
bacteria in the steady state.
The roles of commensal bacteria in
regulating systemic immune activation
are becoming clearer. The studies
described here are consistent with a
report that intestinal microbiota con-
tribute toward DC maturation in the lung
and subsequent T cell priming after influ-
enza infection (Ichinohe et al., 2011).
Importantly, the administration of another
TLR ligand, LPS, was also able to restore
T cell responses in antibiotic-treated
mice, consistent with the ability of poly-
IC to improve survival (Abt et al., 2012).
Other studies have found that certain gut
species influence CD4+ T cell polarization.
For instance, segmented filamentous
bacteria stimulate the development of
IL-17-producing T cells, which contribute
to autoimmune arthritis (Wu et al., 2010).
Alternatively, Clostridium species in the
colon induce anti-inflammatory regu-
latory T cells, which reduce serum IgE
responses (Atarashi et al., 2011). These
studies raise the question of what com-
mensal species are best at inducing anti-
viral immunity. Perhaps this question can
be addressed through monocolonization
experiments in GF mice.
Translocation of microbial products
across the intestinal epithelium and into
the periphery was proposed to be the
mechanism for how commensals poise
the innate immune system. In order for
this to occur, microbial products must
pass through several barriers such as
mucus, epithelial tight junctions, liver
Kupffer cells, and serum antibodies
(Brenchley and Douek, 2012). These
checkpoints help to ensure that micro-
bial translocation is kept to a minimum
in healthy individuals. Recently, it is
becoming clear that perhaps low amounts
of microbial products in the circulation
may be healthy. For example, peptido-
glycan derived from gut bacteria en-
hances neutrophil killing activity through
NOD1 (Clarke et al., 2010). Although the
specific microbiota-derived product(s)
responsible for tonic IFNAR signaling in
mononuclear phagocytes are unknown,
this question can be addressed byity 37, July 27, 2012 ª2012 Elsevier Inc. 11
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Previewsanalyzing mice that are genetically defi-
cient in pattern recognition receptors
such as TLRs and NLRs. It should be
noted that even though tonic stimulation
with commensal products poise innate
immune cells, several diseases are
associated with dysregulated intestinal
permeability, such as inflammatory bowel
disease, hepatitis, HIV infection, pancrea-
titis, alcoholic liver disease, and sepsis
(Brenchley and Douek, 2012). Intriguingly,
type I IFNs were shown to have protec-
tive anti-inflammatory effects in animal
models of colitis (Gonza´lez-Navajas
et al., 2012). This suggests the balance
between controlling systemic virus
infections and limiting autoimmune
inflammation is partially dependent on
commensal-induced type I IFNs. For
instance, IFNAR signaling inhibits Th17
cell function, whereas gut-resident
segmented filamentous bacteria induce
pathogenic Th17 cells that drive autoim-
mune arthritis (Wu et al., 2010).
The polarization of leukocytes into
specialized subsets is associated with
epigenetic modifications of cell type-
specific genes. This can occur during
any stage of hematopoiesis; for instance,
the differentiation of hematopoietic stem
cells into myeloid versus lymphoid line-
ages is accompanied by specific changes
in DNA methylation (Ji et al., 2010). The
new studies from Abt et al. and Ganal
et al. suggest that fully committed APCs12 Immunity 37, July 27, 2012 ª2012 Elsevierequire further chromatin remodeling in
peripheral tissues through microbiota-
induced type I IFNs. This positive feed-
back loop sustains STAT1 phosphoryla-
tion after autocrine IFN receptor signaling
and heightens sensitivity toward systemic
viruses (Figure 1). This contrasts with the
previously held view that APCs are fully
capable of IFN production after their exit
from the bone marrow. Thus, macro-
phages and DCs in commensal-depleted
mice were not intrinsically impaired in
antiviral defense; instead they did not
receive the signals required for transi-
tioning to a poised antiviral state (Fig-
ure 1). The conditioning phase for APCs
requires at least 7 days (Ganal et al.,
2012), suggesting innate immune cells
constantly survey information from the
environment. It is important to note that
microbiota depletion does not result in
global immune suppression, given that
T cell responses against Legionella
pneumophila or herpes simplex virus 2
were normal in antibiotic-treated mice
(Ichinohe et al., 2011). Future directions
include determining whether tonic IFN
signaling affects the function of other
myeloid populations such as plasmacy-
toid DCs, skin Langerhans cells, or liver
Kupffer cells. Perhaps epigenetic pro-
gramming in APCs is also a mechanism
used to help maintain tolerance to self-
antigens. In summary, these exciting find-
ings resolve a link between commensalr Inc.species and systemic immune fitness
that primes the system against patho-
genic threats.REFERENCES
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